The Epistemology of a Positive SARS-CoV-2 Test

被引:0
作者
Rainer Johannes Klement
Prasanta S. Bandyopadhyay
机构
[1] Leopoldina Hospital Schweinfurt,Department of Radiotherapy and Radiation Oncology
[2] Montana State University,Department of History & Philosophy
来源
Acta Biotheoretica | 2021年 / 69卷
关键词
Bayesianism; Confirmation; COVID-19; Evidence; RT-qPCR;
D O I
暂无
中图分类号
学科分类号
摘要
We investigate the epistemological consequences of a positive polymerase chain reaction SARS-CoV test for two relevant hypotheses: (i) V is the hypothesis that an individual has been infected with SARS-CoV-2; (ii) C is the hypothesis that SARS-CoV-2 is the cause of flu-like symptoms in a given patient. We ask two fundamental epistemological questions regarding each hypothesis: First, how much confirmation does a positive test lend to each hypothesis? Second, how much evidence does a positive test provide for each hypothesis against its negation? We respond to each question within a formal Bayesian framework. We construe degree of confirmation as the difference between the posterior probability of the hypothesis and its prior, and the strength of evidence for a hypothesis against its alternative in terms of their likelihood ratio. We find that test specificity—and coinfection probabilities when making inferences about C—were key determinants of confirmation and evidence. Tests with < 87% specificity could not provide strong evidence (likelihood ratio > 8) for V against ¬V regardless of sensitivity. Accordingly, low specificity tests could not provide strong evidence in favor of C in all plausible scenarios modeled. We also show how a positive influenza A test disconfirms C and provides weak evidence against C in dependence on the probability that the patient is influenza A infected given that his/her symptoms are not caused by SARS-CoV-2. Our analysis points out some caveats that should be considered when attributing symptoms or death of a positively tested patient to SARS-CoV-2.
引用
收藏
页码:359 / 375
页数:16
相关论文
共 238 条
  • [1] Bandyopadhyay PS(2006)Acceptibility, evidence, and severity Synthese 148 259-293
  • [2] Brittan GG(2020)COVID-19 diagnosis does not rule out other concomitant diseases Eur J Clin Investig 25 169-193
  • [3] Borghetti A(2000)Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J Mol Endocrinol 25 6-7
  • [4] Ciccullo E(2020)Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset JAMA Intern Med 25 1-8
  • [5] ArturoVisconti E(2020)Letter to the editor: plenty of coronaviruses but no SARS-CoV-2 Eurosurveillance 395 e84-1720
  • [6] Tamburrini G(2020)Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Eurosurveillance 382 1708-2315
  • [7] Simona Di SA(2020)SARS-CoV-2 and influenza virus co-infection Lancet 382 2302-785
  • [8] Bustin H-Y(2020)SARS-CoV-2 infection in Health Care Workers in a large public hospital in Madrid, Spain, during March 2020 medRxiv 71 778-320
  • [9] Cheng S-W(2020)Clinical characteristics of Coronavirus disease 2019 in China N Engl J Med 114 277-1161
  • [10] Jian D-P(2020)Spread of SARS-CoV-2 in the Icelandic Population N Engl J Med 5858 1160-795